Adrenergic, alpha-1B-, Receptor (ADRA1B) Peptid
ADRA1B
Wirt: Synthetic
BP, WB, IHC
-
- Target Alle ADRA1B Produkte
- ADRA1B (Adrenergic, alpha-1B-, Receptor (ADRA1B))
-
Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Verwendungszweck
- α1B-Adrenergic Receptor (extracellular) Negative Control Antigen
- Sequenz
- (C)KNANFTGPNQ TSSNS, correspond ing to amino acid residues 21-35 of human α1B-adrenocept or (Accession P35368).
- Produktmerkmale
- Synthetic peptide, A Blocking peptide for Anti-α1B-Adrenergic Receptor (extracellular) Antibody (ABIN7042897, ABIN7043914 and ABIN7043915)) and Anti-α1B-Adrenergic Receptor (extracellular)-ATTO Fluor-488 Antibody (#ABIN7042898). Intended to be used as a negative control.
- Reinheit
- >70 %
-
-
- Applikationshinweise
- Antigen Preadsorption Control: 1 μg peptide per 1 μg antibody.
- Kommentare
-
Confirmed by amino acid analysis and mass spectrometry.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- 100 μL double distilled water (DDW).
- Konzentration
- 0.4 mg/mL
- Lagerung
- RT,-20 °C
- Informationen zur Lagerung
- Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C.,-20°C.
-
-
Sie sind hier:
